This does not affect requests for the transfer of payments within the same FY. Form FDA 3913 should be completed and submitted to for review and the fee paid will be refunded if appropriate. Instead, payments from closed-out FY cover sheets will only be processed as refunds to the original payors. Beginning in FY 2021, payment transfer requests for cover sheets from a closed-out FY will not be processed. FDA’s FY begins on October 1 and ends on September 30, with the year being designated by the calendar year in which it ends (e.g., FY 2020 begins on October 1, 2019, and ends on September 30, 2020). Starting in fiscal year (FY) 2021, FDA will no longer permit the transferring of GDUFA fee payments from a closed-out fiscal year (FY) cover sheet to a different FY cover sheet.CDER’s Work to Meet User Fee Goals During the Pandemic: This webpage will provide periodic updates on key user fee metrics related to application review and the pre-approval process throughout the COVID-19 pandemic.These fees apply to the period from October 1, 2021, through September 30, 2022. On July 28, 2021, the Food and Drug Administration announced the Generic Drug User Fee Rates for Fiscal Year 2022 in the Federal Register for fees assessed under the Federal Food, Drug, and Cosmetic Act.FY 2022 cover sheets are now available in the User Fee System.

List of shoprite generic drug program